H.C. Wainwright Reiterates Buy Rating on Beam Therapeutics Inc (BEAM)
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/26/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
| Beam Inc. (NASDAQ: BEAM) | Delayed: 24.05 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $24.05 | 52 Week High | $83.60 | |||
| Open | $24.05 | 52 Week Low | $82.96 | |||
| Day High | $24.05 | P/E | 10.74 | |||
| Day Low | $24.05 | EPS | $2.24 | |||
| Volume | 303 | |||||
